Related Experiment Video
Updated: Oct 31, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca2+ Signals
Khaoula Talbi1, Inês Cabrita1, Rainer Schreiber1
1Physiological Institute, University of Regensburg, University Street 31, D-93053 Regensburg, Germany.
Abstract:
Autosomal dominant polycystic kidney disease (ADPKD) is caused by loss of function of PKD1 (polycystin 1) or PKD2 (polycystin 2). The Ca2+-activated Cl- channel TMEM16A has a central role in ADPKD. Expression and function of TMEM16A is upregulated in ADPKD which causes enhanced intracellular Ca2+ signaling, cell proliferation, and ion secretion. We analyzed kidneys from Pkd1 knockout mice and found a more pronounced phenotype in males compared to females, despite similar levels of expression for renal tubular TMEM16A. Cell proliferation, which is known to be enhanced with loss of Pkd1-/-, was larger in male when compared to female Pkd1-/- cells. This was paralleled by higher basal intracellular Ca2+ concentrations in primary renal epithelial cells isolated from Pkd1-/- males. The results suggest enhanced intracellular Ca2+ levels contributing to augmented cell proliferation and cyst development in male kidneys. Enhanced resting Ca2+ also caused larger basal chloride currents in male primary cells, as detected in patch clamp recordings. Incubation of mouse primary cells, mCCDcl1 collecting duct cells or M1 collecting duct cells with dihydrotestosterone (DHT) enhanced basal Ca2+ levels and increased basal and ATP-stimulated TMEM16A chloride currents. Taken together, the more severe cystic phenotype in males is likely to be caused by enhanced cell proliferation, possibly due to enhanced basal and ATP-induced intracellular Ca2+ levels, leading to enhanced TMEM16A currents. Augmented Ca2+ signaling is possibly due to enhanced expression of Ca2+ transporting/regulating proteins.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) is more severe in males due to higher intracellular calcium levels, enhanced cell proliferation, and increased TMEM16A channel activity. Dihydrotestosterone exacerbates these effects in male ADPKD models.
Area of Science:
- Nephrology
- Cell Biology
- Molecular Biology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) results from PKD1 or PKD2 gene mutations.
- The Ca2+-activated Cl- channel TMEM16A plays a key role in ADPKD pathogenesis.
- TMEM16A upregulation in ADPKD leads to increased intracellular Ca2+ signaling, cell proliferation, and ion secretion.
Purpose of the Study:
- To investigate the sex-specific differences in ADPKD phenotype in Pkd1 knockout mice.
- To explore the role of intracellular Ca2+ signaling and TMEM16A in male ADPKD severity.
- To examine the effect of dihydrotestosterone (DHT) on Ca2+ levels and TMEM16A activity in renal cells.
Main Methods:
- Analysis of kidneys from Pkd1 knockout mice (male and female).
- Primary renal epithelial cell culture and patch-clamp recordings.
- Incubation of mouse primary cells and collecting duct cell lines (mCCDcl1, M1) with DHT.
Main Results:
- Pkd1 knockout mice exhibited a more severe phenotype in males than females.
- Male Pkd1-/- cells showed increased proliferation and higher basal intracellular Ca2+ concentrations.
- DHT treatment enhanced basal Ca2+ levels and TMEM16A chloride currents in renal cells.
Conclusions:
- Enhanced intracellular Ca2+ levels and TMEM16A activity contribute to the more severe cystic phenotype in male ADPKD.
- DHT may exacerbate ADPKD progression in males by augmenting Ca2+ signaling and TMEM16A function.
- Sex-specific differences in Ca2+ regulation may underlie differential ADPKD severity.
More Related Videos
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
07:35Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015